What is the role of nitric oxide in murine and human host defense against tuberculosis? Current knowledge

American Journal of Respiratory Cell and Molecular Biology

Volumn 25, Issue 5, 2001, Pages 606-612

  Chan, E D ^a   Chan, J ^a   Schluger, N W ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; DARWINIA; MURINAE; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 0035185373     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.25.5.4487     Document Type: Article

References (82)

1. Pathogenesis of tuberculosis
2. Genetic, biochemical, and clinical features of chronic granulomatous disease
3. The role of phagocytic respiratory burst in host defense against Mycobacterium tuberculosis
4. Chronic granulomatous disease
5. Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice
6. Killing of M. tuberculosis by neutrophils: A nonoxidative process
7. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages
8. Reactive oxygen and nitrogen intermediates in the relationship between hosts and microbial pathogens
9. Mechanisms of nitric oxide-related antimicrobial activity
10. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis
11. Mycobacteriocidal action of exogenous nitric oxide
12. Biochemical regulation of nitric oxide cytotoxicity
13. Cell-mediated immune response in tuberculosis
14. Differential induction of apoptosis by virulent Mycobacterium tuberculosis in resistant and susceptible murine macrophages: Role of nitric oxide and mycobacterial products
15. TNF-alpha and IL-10 modulate the induction of apoptosis by virulent Mycobacterium tuberculosis in murine macrophages
16. Induction of apoptosis in murine macrophages by Mycobacterium tuberculosis is reactive oxygen intemediates-independent
17. Strains of Mycobacterium tuberculosis differ in susceptibility to reactive nitrogen intermediates in vitro
18. Susceptibility of a panel of virulent strains of Mycobacterium tuberculosis to reactive nitrogen intermediates
19. Toxicity of nitrogen oxides and related oxidants on mycobacteria: M. tuberculosis is resistant to peroxynitrite anion
20. Peroxynitrite reductase activity of bacterial peroxiredoxins
21. Identification of nitric oxide synthase as a protective locus against tuberculosis
22. Rapid induction of mRNA for nitric oxide synthase II in rat alveolar macrophages by intratracheal administration of Mycobacterium tuberculosis and Mycobacterium avium
23. Inhibition of virulent Mycobacterium tuberculosis by Bcg (r) and Bcg (s) macrophages correlates with nitric oxide production
24. Depletion of CD4+ T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon γ and nitric oxide synthase 2
25. Effects of aminoguanidine on latent murine tuberculosis
26. Early inhibition of mycobacterial growth by human alveolar macrophages is not due to nitric oxide
27. Mycobacterium tuberculosis (MTB)-stimulated production of nitric oxide by human alveolar macrophages and relationship of nitric oxide production to growth inhibition of MTB
28. 1.25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line
29. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis
30. Difference of nitric oxide production in peripheral blood mononuclear cells and airway epithelial cells between healthy volunteer and patients with tuberculosis
31. Induction of nitric oxide in human monocytes and monocyte cell lines by Mycobacterium tuberculosis
32. Expression of the inducible NO synthase in human monocytic U937 cells allows high output nitric oxide production
33. Upregulation of inducible nitric oxide synthase and cytokine secretion in peripheral blood monocytes from pulmonary tuberculosis patients
34. Human monoclear phagocyte inducible nitric oxide synthase (iNOS): Analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages
35. Alveolar macrophages from C3H/HeJ mice show sensitivity to endotoxin
36. Induction of in vitro human macrophage anti-Mycobacterium tuberculosis activity: Requirement for IFN-γ and primed lymphocytes
37. Mechanism of nitric oxide-dependent killing of Mycobacterium bovis BCG in human alveolar macrophages
38. Nitric oxide modulates interleukin-1β and tumor necrosis factor-α synthesis by alveolar macrophages in pulmonary tuberculosis
39. Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages
40. Expression of inducible nitric oxide synthase in human granulomas and histiocytic reactions
41. Aerosolized interferon-gamma increases nitric oxide production in the bronchoalveolar lavage fluid of patients with active tuberculosis
42. Widespread dissemination of a drug-susceptible strain of Mycobacterium tuberculosis
43. Expression of inducible nitric oxide in human lung epithelial cells
44. Nitric oxide expression in airway epithelial cells in response to tubercle bacilli stimulation
45. Surfactant protein A supresses reactive nitrogen intermediates by alveolar macrophages in response to Mycobacterium tuberculosis
46. Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium boris Bacillus Calmette Guerin-infected dendritic cells
47. Activation of human dendritic ceils following infection with Mycobacterium tuberculosis
48. Mycobacterium tuberculosis-activated dendritic cells induce protective immunity in mice
49. Thymic dendritic cells express inducible nitric oxide synthase and generate nitric oxide in response to self- and alloantigens
50. Induction of nitric oxide synthase in mouse dendritic cells by IFN-γ, endotoxin, and interaction with allogeneic T cells
51. Accumulation of macrophages with dendritic cell characteristics in the pulmonary response to Listeria
52. Reactivation of latent Leishmaniasis by inhibition of inducible nitric oxide synthase
53. Differential responses to challenge with live and dead Mycobacterium bovis Bacillus Calmette-Guerin
54. Fate of Mycobacterium tuberculosis within murine dendritic cells
55. Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: A novel pathway of autocrine macrophage activation
56. The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin- or granzyme-mediated cytolytic mechanisms
57. Activated T cells induce macrophages to produce NO and control Leishmania major in the absence of tumor necrosis factor receptor p55
58. The CD40/CD40 ligand interaction is required for resistance to toxoplasmic encephalitis
59. Disruption of CD40/CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis
60. CD40 ligand is not essential for the development of cell-mediated immunity and resistance to Mycobacterium tuberculosis
61. CD40 ligand is not essential for induction of type 1 cytokine responses or protective immunity after primary or secondary infection with Histoplasma capsulatum
62. CD40 ligand and its role in X-linked hyper-IgM syndrome
63. Generation of nitric oxide by the inducible nitric oxide synthase protects gamma delta T cells from Mycobacterium tuberculosis-induced apoptosis
64. T-cell hyporesponsiveness induced by activated macrophages through nitric oxide production in mice infected with Mycobacterium tuberculosis
65. Interferon gamma eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells
66. Evaluation of the role of mitogen-activated protein kinases in the expression of inducible nitric oxide synthase by IFNγ and TNFα in mouse macrophages
67. Regulation of murine macrophage effector functions by lipoarabinomannan from mycobacterial strains with different degrees of virulence
68. Mechanisms of stimulation of interteukin-1β and tumor necrosis factor-α by Mycobacterium tuberculosis components
69. Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophages
70. Induction of iNOS-NO by lipoarabinomannan of Mycobacterium tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and NFκB signaling pathways
71. Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan
72. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors
73. Purinergic signaling regulates radical-mediated bacterial killing mechanisms in macrophages through a P2X7-independent mechanism
74. A novel antioxidant gene from Mycobacterium tuberculosis
75. noxR3, a novel gene from Mycobacterium tuberculosis, protects Salmonella typhimurium from nitrosative and oxidative stress
76. Alkyl hydroperoxide reductase subunit C (AhpC) protects bacterial and human cells against reactive nitrogen intermediates
77. Response to reactive nitrogen intermediates in Mycobacterium tuberculosis: Induction of the 16-kilodalton alpha-crystallin homolog by exposure to nitric oxide donors
78. Nitrate reduction as a marker for hypoxic shiftdown of Mycobacterium tuberculosis
79. CD8+ CTL from lungs of Mycobacterium tuberculosis-infected mice express perforin in vivo and lyse infected macrophages
80. An antimicrobial activity of cytolytic T cells mediated by granulysin
81. Human purified protein derivative-specific CD4+ T cells use both CD95-dependent and CD95-independent cytolytic mechanisms
82. Granulysin, a T cell product, kills bacteria by altering membrane permeability